The U.S. District Court for the District of Delaware has granted biotech developer DexCom a stay in the patent infringement case filed against it by rival Abbott Laboratories. The court granted the stay pending re-examination of the patents in question by the U.S. Patent and Trademark Office. Abbott has filed a separate action in the same federal court alleging infringement of three additional patents mentioned in the amendment after the court dismissed a request to add the patents to the lawsuit.
August 21, 2006 at 12:00 AM
1 minute read
The original version of this story was published on Law.Com
DexCom Inc., a developer of tests that measure blood sugar levels, said Friday a Delaware court has granted a stay in the patent infringement case filed against it by biotech company Abbott Laboratories Inc.
The U.S. District Court for the District of Delaware granted the stay pending re-examination of the patents in question by the United States Patent and Trademark Office.
Presented by BigVoodoo
Women, Influence & Power in Law Awards honors women lawyers who have made a remarkable difference in the legal profession.
WIPL is the original global forum facilitating women-to-women exchange on leadership and legal issues.
The New England Legal Awards serves as a testament to the outstanding contributions and achievements made by legal professionals.
Please note: Our client is hiring multiple attorneys for their offices in Angleton, Pearland, League City, and Friendswood, TX. While this i...
Philadelphia Plaintiff litigation firm seeks an associate attorney with at least 2 years' experience to join our team handling personal inju...
Position OverviewThe United States Judicial Panel on Multidistrict Litigation is accepting applications for the full-time, permanent positio...
